|
Volumn 5, Issue SUPPL. A, 2001, Pages 73-79
|
Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders
a a a a a a |
Author keywords
CLN2 TPP I; Lysosomal storage disorders; Mutations
|
Indexed keywords
AMINOPEPTIDASE;
CLN 1 PROTEIN;
CLN 2 PROTEIN;
CLN 3 PROTEIN;
LYSOSOME ENZYME;
OLIGOPEPTIDE;
PEPTIDASE;
TRIPEPTIDE;
TRIPEPTIDYL PEPTIDASE I;
UNCLASSIFIED DRUG;
AMINO TERMINAL SEQUENCE;
ARTICLE;
BRAIN TISSUE;
CELL DAMAGE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE SEVERITY;
DNA POLYMORPHISM;
ENZYME ACTIVITY;
ENZYME ASSAY;
FIBROBLAST;
FRACTIONATION;
GENE MUTATION;
GENETIC ANALYSIS;
GENETIC CODE;
GLIA CELL;
GM1 GANGLIOSIDOSIS;
GM2 GANGLIOSIDOSIS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOFLUORESCENCE;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
LYSOSOME STORAGE DISEASE;
MACROPHAGE;
MISSENSE MUTATION;
MOLECULAR GENETICS;
MUCOPOLYSACCHARIDOSIS;
NERVE CELL;
NEURONAL CEROID LIPOFUSCINOSIS;
PATHOLOGY;
POINT MUTATION;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
STAINING;
TISSUE INJURY;
TURNOVER TIME;
WESTERN BLOTTING;
|
EID: 0034924518
PISSN: 10903798
EISSN: None
Source Type: Journal
DOI: 10.1053/ejpn.2000.0439 Document Type: Article |
Times cited : (7)
|
References (20)
|